º´±âº°, Åõ¼® À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° (2024)

º´±âº°, Åõ¼® À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° (1)

½ÃÀ庸°í¼­

»óÇ°ÄÚµå

1490103


Global Wearable Artificial Kidney Market, By Disease Stage, By Dialysis Type, By End User, and Geography

¹ßÇàÀÏ:

|

¸®¼­Ä¡»ç: º´±âº°, Åõ¼® À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° (2) Coherent Market Insights

|

ÆäÀÌÁö Á¤º¸: ¿µ¹®

|

¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¿þ¾î·¯ºí Àΰø½ÅÀå ½ÃÀåÀº 2024³â 91¾ï 1,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2031³â¿¡´Â 224¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024³âºÎÅÍ 2031³â±îÁö 13.8%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í¼­ ¹üÀ§º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ20232024³â ½ÃÀå ±Ô¸ð91¾ï 1,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ2019-2023³â¿¹Ãø ±â°£2024-2031³â
¿¹Ãø ±â°£ 2024-2031³â CAGR:13.80%2031³â °¡Ä¡ ¿¹Ãø224¾ï 6,000¸¸ ´Þ·¯

±×¸². ¿þ¾î·¯ºí Àΰø½ÅÀå ¼¼°è ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2024³â

º´±âº°, Åõ¼® À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° (3)

¿þ¾î·¯ºí Àΰø½ÅÀåÀº ÀÏ¹Ý Åõ¼®±â¿Í ºñ½ÁÇÑ ±â´ÉÀ» ÇÏ´Â ¼ÒÇü ±â°èÀÔ´Ï´Ù. ½ÅÀåÀÌ ´õ ÀÌ»ó ±â´ÉÇÏÁö ¾Ê´Â ȯÀÚ¸¦ À§ÇØ Ã¼¿Ü Ç÷¾×¿¡¼­ ³ëÆó¹°°ú °úµµÇÑ ¼öºÐÀ» °É·¯³À´Ï´Ù. ±âÁ¸ÀÇ Åõ¼® °úÁ¤¿¡¼­´Â ȯÀÚ¸¦ ´ëÇü Åõ¼®±â¿¡ ¸î ½Ã°£ µ¿¾È, ÀÏÁÖÀÏ¿¡ ¿©·¯ ¹ø ¿¬°áÇØ¾ß Çß½À´Ï´Ù. ±×·¯³ª ¿þ¾î·¯ºí Àΰø½ÅÀåÀ» »ç¿ëÇϸé ȯÀÚ´Â Åõ¼® ¼¾Åͳª Åõ¼®±â¿¡ ¹°¸®ÀûÀ¸·Î ¹­¿© ÀÖÁö ¾Ê°íµµ ÀÚÀ¯·Ó°í À¯¿¬ÇÑ ÀÏ»ó »ýÈ°À» ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ÈÞ´ë¿ë ±â¼úÀº ½ÅºÎÀüÁõ ȯÀÚÀÇ »îÀÇ ÁúÀ» Çâ»ó½ÃÅ°´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

¼¼°è ¿þ¾î·¯ºí Àΰø½ÅÀå ½ÃÀåÀÇ ¼ºÀåÀº ¸»±â ½ÅºÎÀüÁõ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, ÀçÅà Ç÷¾×Åõ¼® Ä¡·á ¼ö¿ä Áõ°¡, ÈÞ´ë¿ë ¹× ¿þ¾î·¯ºí ÀÇ·á±â±âÀÇ ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇÑ °ÍÀ¸·Î ºÐ¼®µË´Ï´Ù. ±×·¯³ª ¿þ¾î·¯ºí Àΰø½ÅÀå°ú °ü·ÃµÈ ³ôÀº °³¹ß ºñ¿ë, ±ÔÁ¦ ´ç±¹ÀÇ ±ä ½ÂÀÎ ÀÏÁ¤, ÀϺΠ±¹°¡ÀÇ È¯±Þ Á¤Ã¥ ºÎÁ·Àº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÏ°í ÀÖ½À´Ï´Ù. º¸´Ù È¿À²ÀûÀÌ°í ¼ÒÇüÈ­µÈ ¿þ¾î·¯ºí Åõ¼® ½Ã½ºÅÛÀ» °³¹ßÇϱâ À§ÇÑ ½ÅÈï ½ÃÀåÀÇ ¿¬±¸ °³¹ß È°µ¿Àº ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå Ç÷¹À̾°Ô À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Ư¡

  • ÀÌ º¸°í¼­´Â ¼¼°è ¿þ¾î·¯ºí Àΰø½ÅÀå ½ÃÀåÀ» ½ÉÃþ ºÐ¼®ÇÏ°í 2023³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â) µ¿¾È ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¦½ÃÇÕ´Ï´Ù.
  • ¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ¼ºÀå ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • ¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇÑ °æÀï Àü·« µî¿¡ ´ëÇÑ ÁÖ¿ä ÀλçÀÌÆ®µµ Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ¿þ¾î·¯ºí Àΰø½ÅÀå ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ °³¿äÀ» Á¦°øÇÕ´Ï´Ù.
  • ÁÖ¿ä ±â¾÷À¸·Î´Â B. Braun SE, AWAK Technologies, Blood Purification Technologies Inc., Nextkidney , Triomed AB, SB-KAWASUMI LABORATORIES, INC., Asahi Kasei Medical Co., Ltd., Nanodialysis BV, Semperit AG Holding, KidneyX µîÀÌ ÀÖ½À´Ï´Ù.
  • ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆà ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆà Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.
  • ¿þ¾î·¯ºí Àΰø½ÅÀå ¼¼°è ½ÃÀåÀº ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÏ°í ÀÖ½À´Ï´Ù.
  • ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ¿þ¾î·¯ºí Àΰø½ÅÀå ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

  • Á¶»ç ¸ñÀû
  • °¡Á¤
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map(COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • ¿µÇ⠺м®
  • ½ÃÀå µ¿Çâ
  • ÁÖ¿ä ¹ßÀü
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Á¦Á¶¾÷ü ¸ÅÃâ
  • Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
  • Á¦Ç° ±âµ¿/½ÂÀÎ
  • ºê·£µå¿Í °¡°Ý ºÐ¼®
  • Àڱݰú ÅõÀÚ
  • PEST ºÐ¼®
  • Porters ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ¿þ¾î·¯ºí Àΰø½ÅÀå ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ÀüüÀûÀÎ ¿µÇâ
  • Á¤ºÎ À̴ϼÅƼºê
  • COVID-19ÀÇ ½ÃÀå¿¡ ´ëÇÑ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ¿þ¾î·¯ºí Àΰø½ÅÀå ½ÃÀå, º´±âº°, 2019-2031³â

  • ±Þ¼º ½ÅÀåÁúȯ
  • ¸»±â ½ÅÀ庴

Á¦6Àå ¼¼°èÀÇ ¿þ¾î·¯ºí Àΰø½ÅÀå ½ÃÀå, Åõ¼® À¯Çüº°, 2019-2031³â

  • Ç÷¾× Åõ¼®
  • º¹¸· Åõ¼®

Á¦7Àå ¼¼°èÀÇ ¿þ¾î·¯ºí Àΰø½ÅÀå ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2031³â

  • º´¿ø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • Åõ¼® ¼¾ÅÍ
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ¿þ¾î·¯ºí Àΰø½ÅÀå ½ÃÀå, Áö¿ªº°, 2019-2031³â

Á¦9Àå °æÀï »óȲ

  • ±â¾÷ °³¿ä
    • B. Braun SE
    • AWAK Technologies
    • Blood Purification Technologies Inc.
    • Nextkidney
    • Triomed AB
    • SB-KAWASUMI LABORATORIES, INC.
    • Asahi Kasei Medical Co., Ltd.
    • Nanodialysis BV
    • Semperit AG Holding
    • KidneyX

Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ Á¦¾È

  • Wheel of Fortune
  • ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
  • Coherent Opportunity Map

Á¦11Àå Âü°í¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í¹®Çå
  • Á¶»ç ¹æ¹ý

ksm 24.06.12

Global wearable artificial kidney market is estimated to be valued at USD 9.11 Bn in 2024 and is expected to reach USD 22.46 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.8% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 9.11 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 13.80% 2031 Value Projection: US$ 22.46 Bn

Figure. Global Wearable Artificial Kidney Market Share (%), By Region, 2024

º´±âº°, Åõ¼® À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° (4)

Wearable artificial kidney is a compact machine that works similarly to a regular dialysis machine. It filters waste and excess fluid from the blood outside the body for patients whose kidneys have failed. The traditional dialysis process involves hooking patients to a large dialysis machine for several hours, multiple times a week. However, with wearable artificial kidneys, patients will have the freedom and flexibility to go about their daily lives without being physically tied to a dialysis center or machine. This portable technology could help improve quality of life for kidney failure patients.

Market Dynamics:

Global wearable artificial kidney market growth is driven by rising prevalence of end-stage renal disease, growing geriatric population, increasing demand for home hemodialysis treatment, and technological advancements in portable and wearable medical devices. However, high development costs associated with wearable artificial kidneys, long approval timelines from regulatory authorities, and lack of reimbursem*nt policies in some countries hampers the market growth. Ongoing R&D activities to develop more efficient and miniaturized wearable dialysis systems are expected to create lucrative opportunities for market players over the forecast period.

Key Features of the Study:

  • This report provides an in-depth analysis of the global wearable artificial kidney market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global wearable artificial kidney market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this includes B. Braun SE, AWAK Technologies, Blood Purification Technologies Inc., Nextkidney , Triomed AB, SB-KAWASUMI LABORATORIES, INC., Asahi Kasei Medical Co., Ltd., Nanodialysis BV, Semperit AG Holding, KidneyX.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global wearable artificial kidney market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global wearable artificial kidney market.

Detailed Segmentation-

  • By Disease Stage:
    • Acute Renal Disease
    • End-stage Renal Disease
  • By Dialysis Type:
    • Hemodialysis
    • Peritoneal dialysis
  • By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Dialysis Centers
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Braun SE
    • AWAK Technologies
    • Blood Purification Technologies Inc.
    • Nextkidney
    • Triomed AB
    • SB-KAWASUMI LABORATORIES, INC.
    • Asahi Kasei Medical Co., Ltd.
    • Nanodialysis BV
    • Semperit AG Holding
    • KidneyX

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Disease Stage
    • Market Snapshot, By Dialysis Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Manufacturer Revenue
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Brand and Pricing Analysis
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Wearable Artificial Kidney Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Wearable Artificial Kidney Market, By Disease Stage, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Acute Renal Disease
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • End-stage Renal Disease
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Wearable Artificial Kidney Market, By Dialysis Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Hemodialysis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Peritoneal dialysis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Wearable Artificial Kidney Market, By End User, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Ambulatory Surgical Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Dialysis Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Wearable Artificial Kidney Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dialysis Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dialysis Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
      • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dialysis Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
      • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dialysis Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dialysis Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Dialysis Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)

9. Competitive Landscape

  • Company Profiles
    • B. Braun SE
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • AWAK Technologies
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Blood Purification Technologies Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Nextkidney
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Triomed AB
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • SB-KAWASUMI LABORATORIES, INC.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Asahi Kasei Medical Co., Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Nanodialysis BV
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Semperit AG Holding
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • KidneyX
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
º´±âº°, Åõ¼® À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° (2024)
Top Articles
Latest Posts
Article information

Author: Mrs. Angelic Larkin

Last Updated:

Views: 5999

Rating: 4.7 / 5 (47 voted)

Reviews: 94% of readers found this page helpful

Author information

Name: Mrs. Angelic Larkin

Birthday: 1992-06-28

Address: Apt. 413 8275 Mueller Overpass, South Magnolia, IA 99527-6023

Phone: +6824704719725

Job: District Real-Estate Facilitator

Hobby: Letterboxing, Vacation, Poi, Homebrewing, Mountain biking, Slacklining, Cabaret

Introduction: My name is Mrs. Angelic Larkin, I am a cute, charming, funny, determined, inexpensive, joyous, cheerful person who loves writing and wants to share my knowledge and understanding with you.